GO:2000448 positive regulation of macrophage migration inhibitory factor signaling pathway: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000448 describes any process that activates or increases the frequency, rate or extent of macrophage migration inhibitory factor (MIF) signaling.
• MIF is a pleiotropic cytokine that promotes tumor growth, immune evasion and metastasis across multiple cancers.
• Positive regulation of MIF signaling involves receptor engagement (CD74, CXCR4), MAPK/ERK activation and NF-kB-dependent transcription.
• MIF signaling drives disease progression in leukemia, osteosarcoma, polycystic kidney disease and cardiotoxicity.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect causal roles of MIF pathway components.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study this pathway at scale.
Description
Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine originally identified for its ability to inhibit random migration of macrophages. The Gene Ontology term GO:2000448, positive regulation of macrophage migration inhibitory factor signaling pathway, captures the biological processes that enhance the frequency, rate or extent of MIF signal transduction. This term is critical because MIF signaling is increasingly recognized as a central node in tumor progression, immune evasion and inflammatory disease. Understanding how this pathway is positively regulated provides mechanistic insight into disease pathogenesis and identifies candidate targets for therapeutic intervention. Researchers studying cancer, chronic inflammation and tissue remodeling rely on GO:2000448 to annotate gene sets, interpret transcriptomic data and design functional experiments.
positive regulation of macrophage migration inhibitory factor signaling pathway At A Glance
| GO ID | GO:2000448 |
|---|---|
| GO term | positive regulation of macrophage migration inhibitory factor signaling pathway |
| Ontology | biological_process |
| Synonym | positive regulation of MIF signaling pathway; positive regulation of macrophage migration inhibitory factor signalling pathway |
| Major function | Enhances the frequency, rate or extent of MIF signal transduction |
| Related ligand | Macrophage migration inhibitory factor (MIF) |
| Key receptors | CD74, CXCR4 |
| Downstream pathways | MAPK/ERK, NF-kB, RAS |
| Disease relevance | Leukemia, osteosarcoma, polycystic kidney disease, cardiotoxicity |
What Is GO:2000448?
GO:2000448 is a biological process term defined as any process that activates or increases the frequency, rate or extent of the macrophage migration inhibitory factor signaling pathway. In practical terms, it encompasses molecular events that amplify MIF ligand availability, receptor activation, downstream kinase cascades and transcriptional outputs. This term is a positive regulatory node, distinct from the MIF signaling pathway itself, and is used to annotate genes whose products enhance MIF signal transduction.
Why Is positive regulation of macrophage migration inhibitory factor signaling pathway Important in Cell Biology?
Positive regulation of MIF signaling is important because MIF is a pleiotropic cytokine that promotes tumor growth, angiogenesis, immune evasion and metastasis. Dysregulated MIF signaling is implicated in hematological malignancies, solid tumors, polycystic kidney disease and drug-induced cardiotoxicity. Understanding the positive regulatory mechanisms of this pathway enables researchers to identify biomarkers, design targeted therapies and interpret CRISPR screens.
• MIF signaling promotes tumor growth and metastasis in osteosarcoma through RAS/MAPK activation.
• MIF is a central regulator of immune evasion in multiple cancers.
• Positive regulation of MIF signaling contributes to leukemia pathogenesis.
• MIF promotes cyst growth in polycystic kidney disease.
• MIF signaling is involved in trastuzumab-induced cardiotoxicity via CD74+ cardiac macrophages.
• 4-IPP destabilizes MIF and reduces NF-kB/P-TEFb-mediated c-Myb transcription in osteosarcoma.
• Myeloid-derived apCAFs regulate T cell proportions in HNSCC through MIF-related mechanisms.
• CRISPR screens can identify positive regulators of MIF signaling for therapeutic targeting.
What Happens During positive regulation of macrophage migration inhibitory factor signaling pathway?
MIF ligand availability and secretion
In simple terms: More MIF protein is made or released, so the signal gets stronger.
Positive regulation of MIF signaling can begin with increased MIF expression or secretion from myeloid cells and tumor cells. MIF is stored in preformed pools and released upon stimulation, and its availability is a rate-limiting step for pathway activation.
Receptor engagement and complex formation
In simple terms: MIF binds to its receptors on the cell surface, turning on the signal.
MIF engages CD74 and CXCR4 to initiate signaling. Positive regulation involves enhanced receptor expression or increased affinity, leading to formation of functional receptor complexes that transduce signals into the cell.
Activation of MAPK/ERK and RAS cascades
In simple terms: Inside the cell, a chain of kinases gets switched on.
MIF signaling activates the RAS/MAPK pathway, including ERK phosphorylation, which promotes proliferation and survival. Positive regulation of this step amplifies downstream transcriptional programs.
NF-kB and transcriptional amplification
In simple terms: The signal reaches the nucleus and turns on genes that keep the signal going.
MIF signaling activates NF-kB, which drives transcription of pro-inflammatory and pro-tumorigenic genes. Positive regulation includes NF-kB/P-TEFb complex-mediated transcription of c-Myb and other targets.
Crosstalk with immune cell recruitment
In simple terms: The signal changes how immune cells move and communicate.
MIF signaling influences CD4+ and CD8+ T cell proportions in the tumor microenvironment. Positive regulation can enhance myeloid-derived apCAF functions that modulate T cell responses.
Key Genes Involved in GO:2000448 positive regulation of macrophage migration inhibitory factor signaling pathway
The following genes and proteins are central to positive regulation of MIF signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MIF | Ligand; cytokine that initiates signaling | Target for knockout and point-mutation studies |
| CD74 | MIF receptor; mediates signaling | Knockout models to block MIF signaling |
| CXCR4 | Co-receptor for MIF; chemokine receptor | Knock-in and overexpression models |
| NFKB1 | Transcription factor downstream of MIF | Reporter assays and knockout |
| RELA | NF-kB subunit; drives transcription | Point-mutation studies |
| MAPK1 | ERK2; kinase in MAPK cascade | Knockout to assess pathway dependence |
| MAPK3 | ERK1; kinase in MAPK cascade | Overexpression and knockout |
| HRAS | Small GTPase upstream of MAPK | Point-mutation models |
| KRAS | Small GTPase; oncogenic driver | Knock-in of mutant alleles |
| MYB | Transcription factor regulated by MIF/NF-kB | Knockout and reporter assays |
| CD4 | T cell marker; affected by MIF signaling | Flow cytometry in KO models |
| CD8A | T cell marker; affected by MIF signaling | Flow cytometry in KO models |
| P-TEFb | Transcription elongation complex | Co-IP and knockout |
| CD74+ macrophages | Cardiac macrophage subset | Lineage tracing and KO |
How Is positive regulation of macrophage migration inhibitory factor signaling pathway Regulated?
Positive regulation of MIF signaling is controlled at multiple levels. MIF secretion can be enhanced by inflammatory stimuli. Receptor expression, including CD74 and CXCR4, is regulated by transcription factors such as NF-kB. Downstream, MAPK phosphatases and inhibitors like 4-IPP can destabilize MIF and reduce signaling. The pathway is also modulated by crosstalk with other cytokines and chemokines in the tumor microenvironment.
positive regulation of macrophage migration inhibitory factor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MIF | Leukemia | Knockout and overexpression in leukemia cell lines |
| MIF | Osteosarcoma | Knockout and point-mutation in osteosarcoma cells |
| MIF | Polycystic kidney disease | Knockout mouse models |
| CD74 | Cardiotoxicity | Cardiac macrophage-specific knockout |
| CD74 | HNSCC progression | Knockout in myeloid cells |
MIF signaling in leukemia
MIF is implicated in the pathogenesis of leukemia, where it promotes survival and proliferation of leukemic cells. Positive regulation of MIF signaling contributes to disease progression and represents a potential therapeutic target.
MIF signaling in osteosarcoma
MIF promotes osteosarcoma growth and lung metastasis through activation of the RAS/MAPK pathway. Destabilization of MIF by 4-IPP reduces NF-kB/P-TEFb-mediated c-Myb transcription, suppressing tumorigenesis.
MIF signaling in polycystic kidney disease
MIF promotes cyst growth in polycystic kidney disease, and positive regulation of its signaling exacerbates disease progression.
MIF signaling in cardiotoxicity
CD74+ cardiac macrophages and MIF signaling are involved in trastuzumab-induced cardiotoxicity, highlighting a role in drug-induced cardiac injury.
From positive regulation of macrophage migration inhibitory factor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MIF drive tumor growth? | MIF knockout cell lines and xenografts |
| Does mutant MIF affect signaling? | Point-mutation knock-in of MIF variants |
| Does CD74 mediate MIF signaling? | CD74 knockout and tagged knock-in |
| Does overexpression of MIF enhance metastasis? | MIF overexpression in cancer cells |
| What genes regulate MIF signaling? | CRISPR library screening |
| Does NF-kB drive MIF target genes? | NF-kB knockout and reporter assays |
How to Study the positive regulation of macrophage migration inhibitory factor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for MIF signaling | Identify positive regulators |
| RNA-seq | Transcriptional changes | Downstream targets of MIF |
| Phosphoproteomics | Kinase activation | MAPK/ERK activation |
| Flow cytometry | Immune cell proportions | T cell modulation by MIF |
| Western blot | Protein expression and phosphorylation | MIF and NF-kB levels |
| ELISA | Cytokine secretion | MIF release |
| Immunohistochemistry | Tissue expression | MIF in tumors |
| Reporter assays | Transcriptional activity | NF-kB and c-Myb reporters |
CRISPR knockout screens
Genome-wide CRISPR knockout screens can identify positive regulators of MIF signaling by selecting for cells with altered pathway activity.
Transcriptomics and RNA-seq
RNA-seq after MIF stimulation or knockout reveals transcriptional programs downstream of MIF signaling, including NF-kB targets.
Proteomics and phosphoproteomics
Mass spectrometry can quantify MIF-induced phosphorylation events in MAPK/ERK pathways.
Imaging and flow cytometry
Flow cytometry can assess immune cell populations affected by MIF signaling, such as CD4+ and CD8+ T cells.
How CRISPR Can Be Used to Study GO:2000448 positive regulation of macrophage migration inhibitory factor signaling pathway
Knockout
CRISPR knockout of MIF, CD74 or CXCR4 can abolish MIF signaling and assess its role in tumor growth and immune evasion.
Point Mutation
Point mutations in MIF or its receptors can dissect specific residues required for signaling and receptor binding.
Knock-in
Knock-in of tagged MIF or mutant alleles enables tracking of MIF trafficking and signaling in live cells.
Overexpression
Overexpression of MIF or CD74 can enhance signaling and model disease states such as metastasis.
How EDITGENE Supports positive regulation of macrophage migration inhibitory factor signaling pathway Research
Researchers studying positive regulation of macrophage migration inhibitory factor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway activation, immune modulation or tumor progression. EDITGENE provides validated CRISPR cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of macrophage migration inhibitory factor signaling pathway research.
Frequently Asked Questions About positive regulation of macrophage migration inhibitory factor signaling pathway
What is GO:2000448?
GO:2000448 is the Gene Ontology term for positive regulation of macrophage migration inhibitory factor signaling pathway, describing processes that enhance MIF signaling.
What genes are involved in positive regulation of MIF signaling?
Key genes include MIF, CD74, CXCR4, NFKB1, RELA, MAPK1, MAPK3, HRAS and KRAS.
How does MIF signaling promote cancer?
MIF signaling activates RAS/MAPK and NF-kB pathways, promoting proliferation, survival and immune evasion.
What diseases are linked to MIF signaling?
Leukemia, osteosarcoma, polycystic kidney disease and cardiotoxicity are linked to MIF signaling.
What is the role of CD74 in MIF signaling?
CD74 is a receptor for MIF and mediates downstream signaling in immune and cancer cells.
How can CRISPR be used to study MIF signaling?
CRISPR knockout, point mutation, knock-in and overexpression models can dissect gene function in MIF signaling.
What is the MIF signaling pathway?
The MIF signaling pathway is a cascade initiated by MIF binding to receptors like CD74, leading to MAPK and NF-kB activation.
Is MIF a therapeutic target?
Yes, MIF is considered a therapeutic target in cancer and inflammatory diseases.
What are positive regulators of MIF signaling?
Positive regulators include cytokines that induce MIF secretion, receptors like CD74, and kinases such as ERK.
How to measure MIF signaling activity?
MIF signaling can be measured by phospho-ERK Western blot, NF-kB reporter assays and cytokine ELISAs.
Conclusion
GO:2000448 provides a framework for understanding how MIF signaling is amplified in health and disease. MIF is a pleiotropic cytokine with established roles in cancer, inflammation and tissue remodeling. Positive regulation of this pathway involves ligand availability, receptor engagement, MAPK/ERK activation and NF-kB-dependent transcription. Targeting these regulatory nodes with CRISPR models offers a powerful approach to develop new therapies.
References
- 1. Luo Y et al.. 2021. Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review).. Int J Oncol 59(2) PMID: 34278453
- 2. Bifulco C et al.. 2008. Tumor growth-promoting properties of macrophage migration inhibitory factor.. Curr Pharm Des 14(36):3790-801 PMID: 19128232
- 3. Zheng L et al.. 2022. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis.. Clin Transl Med 12(1):e652 PMID: 35060345
- 4. Ren F et al.. 2025. Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4(+) and CD8(+) T cells.. J Exp Clin Cancer Res 44(1):33 PMID: 39891284
- 5. Wang C et al.. 2017. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.. Cancer Lett 403:271-279 PMID: 28642171
- 6. Aliyarbayova A et al.. 2026. Macrophage Migration Inhibitory Factor (MIF) as a Central Regulator of Tumor Progression and Immune Evasion.. Cell Physiol Biochem 60(4):386-407 PMID: 42536020
- 7. Chen L et al.. 2015. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.. J Clin Invest 125(6):2399-412 PMID: 25961459
- 8. Zhu M et al.. 2025. Exploring the role of the CD74(+) cardiac macrophage subset in trastuzumab cardiotoxicity and its mechanisms.. Biochim Biophys Acta Mol Basis Dis 1871(6):167875 PMID: 40316056
